Inovio Pharmaceuticals - 23 Year Stock Price History | INO

Historical daily share price chart and data for Inovio Pharmaceuticals since 1998 adjusted for splits. The latest closing stock price for Inovio Pharmaceuticals as of October 15, 2021 is 7.02.
  • The all-time high Inovio Pharmaceuticals stock closing price was 191.04 on March 03, 2000.
  • The Inovio Pharmaceuticals 52-week high stock price is 19.00, which is 170.7% above the current share price.
  • The Inovio Pharmaceuticals 52-week low stock price is 5.81, which is 17.2% below the current share price.
  • The average Inovio Pharmaceuticals stock price for the last 52 weeks is 9.34.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Inovio Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 8.9550 9.7300 16.9600 6.2300 7.0200 -20.68%
2020 11.7931 3.2100 31.6900 2.9800 8.8500 168.18%
2019 3.1247 4.2200 5.1000 1.9700 3.3000 -17.50%
2018 4.7034 4.6800 6.1100 3.8800 4.0000 -3.15%
2017 6.2818 7.0700 8.6800 4.1300 4.1300 -40.49%
2016 8.3505 6.4000 11.3900 4.9200 6.9400 3.27%
2015 7.7089 9.3200 10.6000 5.6500 6.7200 -26.80%
2014 10.5773 11.4800 15.2800 8.0000 9.1800 -20.86%
2013 5.1472 2.0128 12.0000 2.0128 11.6000 480.58%
2012 2.2009 1.7400 2.9600 1.6000 1.9980 16.71%
2011 3.2846 4.7200 6.0800 1.4800 1.7120 -62.78%
2010 4.6903 4.4000 5.9600 3.1136 4.6000 0.88%
2009 3.9597 2.0800 12.7200 1.1200 4.5600 119.23%
2008 3.2383 3.7600 5.8000 0.6400 2.0800 -43.48%
2007 9.7928 13.1600 16.6800 3.4000 3.6800 -72.04%
2006 10.3756 9.8000 14.3600 8.0000 13.1600 44.93%
2005 12.5271 15.6000 20.0400 7.9600 9.0800 -42.39%
2004 19.2892 22.2400 30.4000 10.0000 15.7600 -21.20%
2003 10.8533 4.4800 22.0800 3.8400 20.0000 362.96%
2002 6.6330 10.4000 13.6000 2.2400 4.3200 -57.81%
2001 14.7855 15.0000 27.2000 6.0800 10.2400 -31.73%
2000 53.4853 54.0000 191.0400 12.0000 15.0000 -71.15%
1999 51.2086 55.0080 65.0080 37.0080 52.0000 -1.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.477B $0.007B
Inovio Pharmaceuticals, Inc., formerly known as Inovio Biomedical Corporation, is engaged in the discovery, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The Company's electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. Inovio's clinical programs include human papillomavirus (HPV)/cervical cancer (therapeutic), avian influenza (preventative), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) vaccines. It is advancing preclinical research for a universal seasonal/pandemic influenza vaccine. The Company's partners and collaborators include University of Pennsylvania, National Microbiology Laboratory of the Public Health Agency of Canada, NIAID, Merck, ChronTech, University of Southampton, and HIV Vaccines Trial Network. Inovio Pharmaceuticals, Inc. is headquartered in Blue Bell, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00